Nature Communications (Mar 2022)

A single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response

  • G. Gambardella,
  • G. Viscido,
  • B. Tumaini,
  • A. Isacchi,
  • R. Bosotti,
  • D. di Bernardo

DOI
https://doi.org/10.1038/s41467-022-29358-6
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

The impact of tumour heterogeneity on drug response in breast cancer is not fully understood. Here, the authors characterise cell lines from all main breast cancer subtypes using single-cell RNA-seq and train a deconvolution algorithm to predict drug responses in heterogeneous tumour cell populations.